# ANRO (Alto Neuroscience, Inc.) - SEC EDGAR Financial Statements

> Alto Neuroscience, Inc. reported $326.5M in total assets and a net loss of $95.18M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/ANRO
- Markdown: https://convexityos.com/fundamentals/ANRO.md
- SEC CIK: 0001999480
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:29 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001999480&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$100.5M | Operating profit |
| Net Income | FY 2025 | -$95.18M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$2.05 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$79.68M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $319.3M | Total debt: $15.52M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Research & Development | $45.62M | $47.00M | $30.29M |
| Total Operating Expenses | $66.36M | $68.61M | $37.81M |
| **Operating Income** | -$66.36M | -$68.61M | -$37.81M |
| **EBITDA** | -$65.70M | -$68.11M | -$37.44M |
| Interest Income | $6.60M | $8.85M | $2.35M |
| Interest Expense | $2.47M | $1.38M | $1.37M |
| Income Tax Expense | $0 | $0 | $0 |
| **Net Income** | -$63.24M | -$61.43M | -$36.30M |
| Basic EPS | -$2.19 | -$2.50 | -$9.73 |
| **Diluted EPS** | -$2.19 | -$2.50 | -$9.73 |
| Basic Shares Outstanding | 28.9M | 24.6M | 3.7M |
| Diluted Shares Outstanding | 28.9M | 24.6M | 3.7M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $18.16M | $22.11M | $20.29M | $12.00M | $10.53M | $13.12M | $9.97M | $10.80M |
| Total Operating Expenses | $27.23M | $29.13M | $27.14M | $17.05M | $14.95M | $18.68M | $15.68M | $17.00M |
| **Operating Income** | -$27.23M | -$29.13M | -$27.14M | -$17.05M | -$14.95M | -$18.68M | -$15.68M | -$17.00M |
| **EBITDA** | -$27.12M | -$28.93M | -$26.95M | -$16.90M | -$14.75M | -$18.58M | -$15.51M | -$16.83M |
| Interest Income | $2.60M | $2.11M | $1.56M | $1.56M | $1.53M | $1.68M | $1.83M | $2.13M |
| Interest Expense | $463K | $491K | $545K | $575K | $650K | $646K | $598K | $333K |
| Income Tax Expense | -- | -- | -- | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$25.12M | -$27.64M | -$26.24M | -$16.18M | -$14.18M | -$17.71M | -$15.17M | -$15.20M |
| Basic EPS | -$0.54 | -$0.65 | -$0.80 | -- | -$0.52 | -$0.65 | -$0.56 | -- |
| **Diluted EPS** | -$0.54 | -$0.65 | -$0.80 | -- | -$0.52 | -$0.65 | -$0.56 | -- |
| Basic Shares Outstanding | 46.5M | 42.8M | 32.9M | -- | 27.1M | 27.1M | 27.0M | -- |
| Diluted Shares Outstanding | 46.5M | 42.8M | 32.9M | -- | 27.1M | 27.1M | 27.0M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Cash & Cash Equivalents | $176.5M | $168.2M | $82.55M |
| **Cash & Short-Term Investments** | $176.5M | $168.2M | $82.55M |
| Other Current Assets | -- | $30K | $112K |
| **Total Current Assets** | $177.7M | $169.3M | $85.39M |
| Property, Plant & Equipment, Net | $1.87M | $2.67M | $1.11M |
| **Total Non-Current Assets** | $6.97M | $8.21M | $1.24M |
| **Total Assets** | $184.7M | $177.5M | $86.63M |
| Accounts Payable | $1.88M | $1.58M | $1.07M |
| Short-Term Debt | $585K | $0 | $0 |
| **Total Current Liabilities** | $11.32M | $10.01M | $5.61M |
| Long-Term Debt | $16.17M | $10.25M | $9.86M |
| **Total Non-Current Liabilities** | $22.22M | $16.07M | $11.21M |
| **Total Liabilities** | $33.55M | $26.08M | $16.82M |
| **Total Debt (incl. Leases)** | $21.73M | $15.64M | $9.99M |
| Retained Earnings | -$201.6M | -$138.4M | -$76.97M |
| Accumulated Other Comp. Income | $22K | -$101K | -$79K |
| **Total Stockholders' Equity** | $151.1M | $151.5M | -$71.67M |
| Total Equity | $151.1M | $151.5M | -$71.67M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $319.3M | $243.7M | $263.8M | $176.5M | $137.8M | $147.6M | $160.8M | $168.2M |
| **Cash & Short-Term Investments** | $319.3M | $243.7M | $263.8M | $176.5M | $137.8M | $147.6M | $160.8M | $168.2M |
| Other Current Assets | -- | -- | -- | -- | -- | -- | $23K | $30K |
| **Total Current Assets** | $323.2M | $247.3M | $269.1M | $177.7M | $139.4M | $149.8M | $163.5M | $169.3M |
| Property, Plant & Equipment, Net | $1.87M | $2.05M | $2.23M | $1.87M | $2.03M | $2.31M | $2.48M | $2.67M |
| **Total Non-Current Assets** | $3.31M | $6.75M | $7.13M | $6.97M | $7.56M | $8.03M | $8.39M | $8.21M |
| **Total Assets** | $326.5M | $254.1M | $276.3M | $184.7M | $147.0M | $157.9M | $171.9M | $177.5M |
| Accounts Payable | $3.47M | $4.02M | $3.37M | $1.88M | $2.06M | $1.67M | $1.38M | $1.58M |
| Short-Term Debt | $4.51M | $3.77M | $2.14M | $585K | -- | -- | -- | $0 |
| **Total Current Liabilities** | $17.84M | $16.65M | $13.12M | $11.32M | $9.04M | $8.13M | $7.26M | $10.01M |
| Long-Term Debt | $8.97M | $12.42M | $13.88M | $16.17M | $20.31M | $20.12M | $19.94M | $10.25M |
| **Total Non-Current Liabilities** | $12.14M | $18.16M | $19.77M | $22.22M | $26.40M | $26.34M | $25.56M | $16.07M |
| **Total Liabilities** | $29.98M | $34.82M | $32.89M | $33.55M | $35.45M | $34.47M | $32.82M | $26.08M |
| **Total Debt (incl. Leases)** | $15.52M | $20.83M | $20.88M | $21.73M | $25.40M | $25.31M | $25.23M | $15.64M |
| Retained Earnings | -$280.6M | -$255.5M | -$227.9M | -$201.6M | -$185.5M | -$171.3M | -$153.6M | -$138.4M |
| Accumulated Other Comp. Income | $19K | $17K | $13K | $22K | $14K | $31K | $14K | -$101K |
| **Total Stockholders' Equity** | $296.5M | $219.2M | $243.4M | $151.1M | $111.6M | $123.4M | $139.1M | $151.5M |
| Total Equity | $296.5M | $219.2M | $243.4M | $151.1M | $111.6M | $123.4M | $139.1M | $151.5M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Net Income | -$63.24M | -$61.43M | -$36.30M |
| Depreciation & Amortization | $661K | $502K | $373K |
| Stock-Based Compensation | $8.11M | $7.63M | $2.89M |
| Change in Payables | $221K | $516K | -$632K |
| **Operating Cash Flow** | -$51.77M | -$47.42M | -$33.45M |
| Capital Expenditure | -$24K | -$2.08M | -$470K |
| **Free Cash Flow** | -$51.79M | -$49.50M | -$33.92M |
| **Investing Cash Flow** | -$24K | -$2.08M | -$470K |
| **Financing Cash Flow** | $60.08M | $135.7M | $68.13M |
| **Net Change in Cash** | $8.26M | $86.18M | $34.20M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$25.12M | -$27.64M | -$26.24M | -$16.18M | -$14.18M | -$17.71M | -$15.17M | -$15.20M |
| Depreciation & Amortization | $100K | $200K | $184K | $157K | $200K | $100K | $171K | $170K |
| Stock-Based Compensation | $3.52M | $3.55M | $2.82M | $1.95M | $2.19M | $2.00M | $1.97M | $1.57M |
| Change in Payables | -$544K | $652K | $1.49M | -$297K | $461K | $323K | -$266K | -$762K |
| **Operating Cash Flow** | -$20.76M | -$19.76M | -$27.09M | -$11.52M | -$9.92M | -$13.78M | -$16.56M | -$13.02M |
| Capital Expenditure | $0 | $0 | -$556K | $0 | $0 | $0 | -$24K | -$506K |
| **Free Cash Flow** | -$20.76M | -$19.76M | -$27.65M | -$11.52M | -$9.92M | -$13.78M | -$16.58M | -$13.53M |
| **Investing Cash Flow** | $0 | $0 | -$556K | $0 | $0 | $0 | -$24K | -$506K |
| **Financing Cash Flow** | $96.36M | -$273K | $114.9M | $50.19M | $153K | $613K | $9.13M | $49K |
| **Net Change in Cash** | $75.61M | -$20.03M | $87.28M | $38.67M | -$9.77M | -$13.17M | -$7.47M | -$13.47M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Return on Equity (ROE) | -41.8% | -40.6% | -- |
| Return on Assets (ROA) | -34.2% | -34.6% | -41.9% |
| Current Ratio | 15.69x | 16.92x | 15.22x |
| Quick Ratio | 15.58x | 16.81x | 14.71x |
| Debt to Equity | 0.14x | 0.10x | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -32.1% | -38.4% | -30.5% | -41.8% | -55.8% | -52.6% | -45.4% | -40.6% |
| Return on Assets (ROA) | -29.2% | -33.2% | -26.9% | -34.2% | -42.3% | -41.1% | -36.8% | -34.6% |
| Current Ratio | 18.12x | 14.85x | 20.52x | 15.69x | 15.42x | 18.43x | 22.53x | 16.92x |
| Quick Ratio | 17.90x | 14.64x | 20.11x | 15.58x | 15.24x | 18.16x | 22.15x | 16.81x |
| Debt to Equity | 0.05x | 0.10x | 0.09x | 0.14x | 0.23x | 0.21x | 0.18x | 0.10x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
